Clinical, muscle pathological, and genetic features of Japanese facioscapulohumeral muscular dystrophy 2 (FSHD2) patients with SMCHD1 mutations

Authors:

Abstract
No abstract available
Funding Information
  • Japan Agency for Medical Research and Development (H25-Shinkei Kin-Ippan-004, H26-Itaku (Nan)-Ippan-081)
  • JSPS KAKENHI (24659437)
  • National Center of Neurology and Psychiatry (26-8, 26-7, 25-5)

This publication has 28 references indexed in Scilit: